Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year revenue CAGR of 50.2%
Concerns1
- Low return on equity of 0.8%
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ713.00 Cr | β | βΉ40.00 Cr | β | β | 3.2% | 52.7% | 344.4% |
| Mar 2024 | βΉ467.00 Cr | β | βΉ9.00 Cr | β | β | 0.8% | 118.2% | 50.0% |
| Mar 2023 | βΉ214.00 Cr | β | βΉ6.00 Cr | β | β | 0.5% | 46.6% | 0.0% |
| Mar 2022 | βΉ146.00 Cr | β | βΉ6.00 Cr | β | β | 0.5% | 114.7% | -166.7% |
| Mar 2021 | βΉ68.00 Cr | β | βΉ-9.00 | β | β | -1.7% | 11.5% | -64.0% |
| Mar 2020 | βΉ61.00 Cr | β | βΉ-25.00 | β | β | -6.3% | 510.0% | 733.3% |
| Mar 2019 | βΉ10.00 Cr | β | βΉ-3.00 | β | β | -1.6% | 11.1% | -81.3% |
| Mar 2018 | βΉ9.00 Cr | β | βΉ-16.00 | β | β | -8.6% | 350.0% | 700.0% |
| Mar 2017 | βΉ2.00 Cr | β | βΉ-2.00 | β | β | -2.3% | 0.0% | -50.0% |
| Mar 2016 | βΉ2.00 Cr | β | βΉ-4.00 | β | β | -3.7% | 0.0% | -20.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 768 |
| Total Expenses | 675 |
| EBIT / Operating Profit | 94 |
| OPM % | 12% |
| Other Income | 10 |
| Finance Costs | 9 |
| Depreciation & Amortisation | 27 |
| Profit Before Tax | 68 |
| Tax % | - |
| Net Profit / PAT | 53 |
| EPS (βΉ) | 4.38 |
| Dividend Payout % | - |
Peer Comparison
Consumer Discretionary sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Medplus Health Services Limitedthis co. | βΉ10.13 K Cr | βΉ713.00 Cr | 193.00 | 7.95 | 260.92 | 52.7% |
| Titan Company Limited | βΉ3.76 L Cr | βΉ54.84 K Cr | 96.60 | 21.09 | 69.49 | 16.4% |
| Eternal Limited | βΉ2.84 L Cr | βΉ8.62 K Cr | 120.00 | 7.95 | 193.91 | 30.1% |
| Avenue Supermarts Limited | βΉ2.49 L Cr | βΉ57.79 K Cr | 79.80 | 10.46 | 57.86 | 16.7% |
| Trent Ltd [Lakme Ltd] | βΉ1.39 L Cr | βΉ16.67 K Cr | 82.40 | 21.09 | 49.02 | 39.8% |
| Marico Limited | βΉ98.15 K Cr | βΉ7.58 K Cr | 52.30 | 19.38 | 63.51 | 8.3% |
| SWIGGY LIMITED | βΉ96.87 K Cr | βΉ8.80 K Cr | β | 7.26 | -63.92 | 38.0% |
| Industry Average | β | βΉ4.70 K Cr | 80.04 | 7.96 | 62.25 | 24.3% |